Clostebol acetate
| Clinical data | |
|---|---|
| Trade names | Macrobin, Steranabol, Alfa-Trofodermin, Megagrisevit |
| Other names | 4-Chlorotestosterone acetate; 4-CLTA; 4-Chloroandrost-4-en-17β-ol-3-one 17β-acetate; NSC-72159 |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.565 |
| Chemical and physical data | |
| Formula | C21H29ClO3 |
| Molar mass | 364.91 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Clostebol acetate (BAN; brand names Macrobin, Steranabol, Alfa-Trofodermin, and Megagrisevit; also known as 4-chlorotestosterone 17β-acetate (4-CLTA) or 4-chloroandrost-4-en-17β-ol-3-one 17β-acetate) is a synthetic, injected anabolic-androgenic steroid (AAS) and a derivative of testosterone that is marketed in Germany and Italy. It is an androgen ester – specifically, the C17β acetate ester of clostebol (4-chlorotestosterone) – and acts as a prodrug of clostebol in the body. Clostebol acetate is administered via intramuscular injection.